Neurological Sciences最新文献

筛选
英文 中文
Efficacy of neuromodulation and rehabilitation approaches on pain relief in patients with spinal cord injury: a systematic review and meta-analysis. 神经调节和康复方法对脊髓损伤患者疼痛缓解的疗效:系统回顾和荟萃分析。
IF 2.7 4区 医学
Neurological Sciences Pub Date : 2025-07-01 Epub Date: 2025-03-11 DOI: 10.1007/s10072-025-08077-y
Simona Portaro, Angelo Alito, Giulia Leonardi, Nicola Marotta, Adriana Tisano, Daniele Bruschetta, Umile Giuseppe Longo, Antonio Ammendolia, Demetrio Milardi, Alessandro de Sire
{"title":"Efficacy of neuromodulation and rehabilitation approaches on pain relief in patients with spinal cord injury: a systematic review and meta-analysis.","authors":"Simona Portaro, Angelo Alito, Giulia Leonardi, Nicola Marotta, Adriana Tisano, Daniele Bruschetta, Umile Giuseppe Longo, Antonio Ammendolia, Demetrio Milardi, Alessandro de Sire","doi":"10.1007/s10072-025-08077-y","DOIUrl":"10.1007/s10072-025-08077-y","url":null,"abstract":"<p><strong>Introduction: </strong>Spinal cord injury (SCI) is a debilitating neurological condition that causes physical dependency, psychological distress, and financial burden. Pain is a common consequence of SCI, significantly impacting quality of life. Effective pain management in SCI is challenging and requires multifaceted approaches. Among rehabilitation methods, non-invasive brain stimulation techniques such as repetitive transcranial magnetic stimulation (rTMS), theta burst stimulation (TBS), transcranial direct current stimulation (tDCS), transcutaneous electrical nerve stimulation (TENS), and virtual reality (VR) have been explored. This study aims to evaluate the efficacy of rehabilitation and non-invasive brain stimulation techniques on pain relief in SCI patients.</p><p><strong>Methods: </strong>A systematic review of the literature was conducted using PubMed, Scopus, and ScienceDirect with the formula (\"spinal cord injury\") AND (\"pain\"). Risk of bias was assessed using the Cochrane Risk of Bias Tool.</p><p><strong>Results: </strong>Sixteen studies involving 319 patients were included. Patients in the control groups received: rTMS in seven trials, tDCS in seven trials, TBS in one trial, and TENS combined with VR in one trial. The trials analyzed were of poor methodological quality, characterized by small sample sizes, weak power analyses, varying clinical scores, and non-comparable follow-up periods. No major complications or serious adverse events were reported.</p><p><strong>Conclusion: </strong>Results were inconsistent, with no solid evidence supporting the superiority of rehabilitation techniques over comparator treatments. However, the favorable safety profile and positive outcomes in some measures suggest potential benefits for pain management and quality of life. Further studies are necessary to better understand SCI-related pain and optimize treatment strategies.</p>","PeriodicalId":19191,"journal":{"name":"Neurological Sciences","volume":" ","pages":"2995-3020"},"PeriodicalIF":2.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143605439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cerebrospinal fluid metabolomics reveals predictive biomarkers of nusinersen therapy efficacy in type II and type III spinal muscular atrophy patients. 脑脊液代谢组学揭示了nusinersen治疗II型和III型脊髓性肌萎缩患者疗效的预测性生物标志物。
IF 2.7 4区 医学
Neurological Sciences Pub Date : 2025-06-12 DOI: 10.1007/s10072-025-08267-8
Dan Li, Na Sun, Hongbo Wu, Xueying Wang, Yongjing Shi, Lin Yang, Shaoping Huang, Kun Zhang, Changhong Yang
{"title":"Cerebrospinal fluid metabolomics reveals predictive biomarkers of nusinersen therapy efficacy in type II and type III spinal muscular atrophy patients.","authors":"Dan Li, Na Sun, Hongbo Wu, Xueying Wang, Yongjing Shi, Lin Yang, Shaoping Huang, Kun Zhang, Changhong Yang","doi":"10.1007/s10072-025-08267-8","DOIUrl":"https://doi.org/10.1007/s10072-025-08267-8","url":null,"abstract":"<p><strong>Background and purpose: </strong>This study investigated the predictive value of clinical characteristics and cerebrospinal fluid (CSF) metabolites for nusinersen efficacy in children with spinal muscular atrophy (SMA).</p><p><strong>Methods: </strong>In this study, clinical data and CSF samples were collected. We used liquid chromatography-tandem mass spectrometry to analyze CSF metabolites from 42 patients with type II and type III SMA.</p><p><strong>Results: </strong>Although clinical indicators, such as age at treatment initiation and disease duration, did not predict the clinical efficacy of nusinersen, we identified 47 differentially expressed metabolites between effective- and ineffective-treatment patients with type II disease and 109 metabolites in patients with type III disease. Additionally, KEGG-enriched pathway analysis revealed differences in several pathways between the effective- and ineffective-treatment groups for both types II and III. N-myristoyl arginine and 1,1,1,2,2,2-Pentafluoro-7-phenylheptan-3-one were negatively associated with Hammersmith Functional Motor Scale Expanded changes in patients with type III and type III SMA. Furthermore, multivariate receiver operating characteristic curve analysis indicated that differential metabolites have some accuracy in predicting SMA treatment efficacy.</p><p><strong>Conclusion: </strong>This study identified CSF metabolites that are predictive of nusinersen efficacy. The results of this study may guide the development of adjunctive therapies for improving the efficacy of nusinersen.</p>","PeriodicalId":19191,"journal":{"name":"Neurological Sciences","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144275462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role and Mechanisms of G protein-coupled receptors in Parkinson's disease. G蛋白偶联受体在帕金森病中的作用及机制
IF 2.7 4区 医学
Neurological Sciences Pub Date : 2025-06-11 DOI: 10.1007/s10072-025-08260-1
Yajun Jing, Peisen Yao, Honglin Zhu, Lianghong Yu, Yuanxiang Lin, Dezhi Kang
{"title":"The Role and Mechanisms of G protein-coupled receptors in Parkinson's disease.","authors":"Yajun Jing, Peisen Yao, Honglin Zhu, Lianghong Yu, Yuanxiang Lin, Dezhi Kang","doi":"10.1007/s10072-025-08260-1","DOIUrl":"https://doi.org/10.1007/s10072-025-08260-1","url":null,"abstract":"<p><p>This comprehensive review meticulously examines the pivotal and multifaceted role of G protein-coupled receptors (GPCRs) in the complex pathogenesis of Parkinson's disease (PD), a neurodegenerative disorder that profoundly impacts motor control and cognitive function. Initially, we introduce the fundamental concepts of GPCRs, delving into their intricate structures and diverse functions within the nervous system, highlighting their importance as key players in cellular communication and signal transduction. Following this foundational overview, we thoroughly analyze specific GPCRs that have been closely associated with the onset and progression of PD, exploring the intricate mechanisms by which they influence disease progression through the nuanced regulation of neurotransmitter release, complex signaling pathways, and crucial aspects of cell survival. Furthermore, we engage in a detailed discussion regarding the promising prospects of GPCRs as potential therapeutic targets for intervention in PD, emphasizing the significance of recent groundbreaking research findings that shed light on the therapeutic implications of modulating GPCR activity. Finally, drawing upon the latest advancements in research, we propose insightful directions for future studies, as well as a thoughtful consideration of the myriad challenges that lie ahead in this dynamic and rapidly evolving field of study, which holds the potential to enhance our understanding of PD and pave the way for innovative treatment strategies.</p>","PeriodicalId":19191,"journal":{"name":"Neurological Sciences","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144275463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: A new swallowing supplement for dysphagia in patients with Parkinson's disease. 更正:一种用于帕金森病患者吞咽困难的新型吞咽补剂。
IF 2.7 4区 医学
Neurological Sciences Pub Date : 2025-06-11 DOI: 10.1007/s10072-025-08285-6
Eungseok Oh, Sungju Jee, Bum Keun Kim, Jung Seon Lee, Kanghee Cho, Soyoung Ahn
{"title":"Correction to: A new swallowing supplement for dysphagia in patients with Parkinson's disease.","authors":"Eungseok Oh, Sungju Jee, Bum Keun Kim, Jung Seon Lee, Kanghee Cho, Soyoung Ahn","doi":"10.1007/s10072-025-08285-6","DOIUrl":"https://doi.org/10.1007/s10072-025-08285-6","url":null,"abstract":"","PeriodicalId":19191,"journal":{"name":"Neurological Sciences","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144266884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the editor, regarding "Stroke, idiopathic thrombocytopenic purpura and avatrombopag: two cases of coincident events" recently published by Boy and colleagues. 致编辑的信,关于“中风,特发性血小板减少性紫癜和avatrombbag:两个同时发生的事件”,最近由Boy和他的同事发表。
IF 2.7 4区 医学
Neurological Sciences Pub Date : 2025-06-11 DOI: 10.1007/s10072-025-08288-3
Senta Frol, Matjaž Sever
{"title":"Letter to the editor, regarding \"Stroke, idiopathic thrombocytopenic purpura and avatrombopag: two cases of coincident events\" recently published by Boy and colleagues.","authors":"Senta Frol, Matjaž Sever","doi":"10.1007/s10072-025-08288-3","DOIUrl":"https://doi.org/10.1007/s10072-025-08288-3","url":null,"abstract":"","PeriodicalId":19191,"journal":{"name":"Neurological Sciences","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144266885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic inflammatory demyelinating polyneuropathy in end-stage renal disease patients: a case series study. 终末期肾病患者慢性炎性脱髓鞘性多神经病变:病例系列研究。
IF 2.7 4区 医学
Neurological Sciences Pub Date : 2025-06-11 DOI: 10.1007/s10072-025-08278-5
Yize Li, Yakun Wu, Zhenyu Li, Jieyu Li, Ping Li, Zhiying Xie, Yiming Zheng, Jianwen Deng, He Lv, Zhaoxia Wang, Yun Yuan, Lingchao Meng
{"title":"Chronic inflammatory demyelinating polyneuropathy in end-stage renal disease patients: a case series study.","authors":"Yize Li, Yakun Wu, Zhenyu Li, Jieyu Li, Ping Li, Zhiying Xie, Yiming Zheng, Jianwen Deng, He Lv, Zhaoxia Wang, Yun Yuan, Lingchao Meng","doi":"10.1007/s10072-025-08278-5","DOIUrl":"https://doi.org/10.1007/s10072-025-08278-5","url":null,"abstract":"<p><strong>Objectives: </strong>The occurrence of chronic inflammatory demyelinating polyneuropathy (CIDP) in patients with end-stage renal disease (ESRD) has been rarely studied. This study was intended to explore the clinical, electrophysiological and neuropathological features of six patients with CIDP and ESRD.</p><p><strong>Methods: </strong>The medical records collected in Peking University First Hospital between 2021 and 2024 were reviewed before six patients were identified who had developed CIDP with ESRD. The data on their clinical features, electrophysiological tests, nerve ultrasound, laboratory examinations and sural biopsies was retrieved.</p><p><strong>Results: </strong>All the six patients were males ages 35 to 63. Before and after dialysis, all these patients presented with varying degrees of limb sensory impairment and weakness, and reduced or absent tendon reflexes. Albuminocytologic dissociation of cerebrospinal fluid was observed in all of them. Nerve conduction studies identified the demyelinating features while nerve ultrasound showed nerve enlargement of upper limbs. Sural nerve biopsies showed mild to moderate decreases of myelinated nerve fiber density, with differences between different nerve fascicles. Thin myelinated fibers were seen, without onion bulb-like structure. Varying degrees of axonal degeneration with regeneration were identified in some of these patients. Immunotherapy was effective in all these patients.</p><p><strong>Conclusions: </strong>The diagnosis of CIDP should be considered if an ESRD patient develops progressive demyelinating neuropathy. Immune therapy has shown clinical efficacy despite the underlying mechanisms that remain poorly understood.</p>","PeriodicalId":19191,"journal":{"name":"Neurological Sciences","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144266883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research progress of chronic fatigue in neurodegenerative diseases. 慢性疲劳在神经退行性疾病中的研究进展。
IF 2.7 4区 医学
Neurological Sciences Pub Date : 2025-06-10 DOI: 10.1007/s10072-025-08254-z
Luxuan Xia, Liye Wang, Wenyang Tian, Qianyu Zhao, Xinning Zhang, Shenghua Kang, Yao Wang, Xiaoxue Li, Wenxuan Guo, Jingmei Zhao, Yuanxin Zhang, Zhigang Chen, Nannan Li
{"title":"Research progress of chronic fatigue in neurodegenerative diseases.","authors":"Luxuan Xia, Liye Wang, Wenyang Tian, Qianyu Zhao, Xinning Zhang, Shenghua Kang, Yao Wang, Xiaoxue Li, Wenxuan Guo, Jingmei Zhao, Yuanxin Zhang, Zhigang Chen, Nannan Li","doi":"10.1007/s10072-025-08254-z","DOIUrl":"https://doi.org/10.1007/s10072-025-08254-z","url":null,"abstract":"","PeriodicalId":19191,"journal":{"name":"Neurological Sciences","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144258544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frequency of anti-GQ1b IgG antibody in miller fisher syndrome: a Chinese single center study. 米勒费雪综合征中抗gq1b IgG抗体频率的中国单中心研究
IF 2.7 4区 医学
Neurological Sciences Pub Date : 2025-06-09 DOI: 10.1007/s10072-025-08290-9
Pengfei Shao, Wenhui Wu, Xin Zhang, Haifeng Chen, Yun Xu, Qing Ye
{"title":"Frequency of anti-GQ1b IgG antibody in miller fisher syndrome: a Chinese single center study.","authors":"Pengfei Shao, Wenhui Wu, Xin Zhang, Haifeng Chen, Yun Xu, Qing Ye","doi":"10.1007/s10072-025-08290-9","DOIUrl":"https://doi.org/10.1007/s10072-025-08290-9","url":null,"abstract":"<p><strong>Background: </strong>The anti-GQ1b IgG antibody has been traditionally regarded as a sensitive marker for Miller Fisher syndrome (MFS). Nevertheless, its prevalence might vary across regions and could be affected by the coronavirus disease 2019 (COVID-19) pandemic. This retrospective study was designed to evaluate the positivity rate of the anti-GQ1b IgG antibody among MFS patients admitted to a single Chinese center and to examine the influence of the COVID-19 pandemic thereon.</p><p><strong>Methods: </strong>We retrospectively analyzed the medical records of patients diagnosed with MFS and admitted to our hospital from January 2018 to March 2024. Anti-ganglioside antibodies were tested in acute-phase serum samples using enzyme-linked immunosorbent assay (ELISA) or immune-dot assays.</p><p><strong>Results: </strong>Of the 72 patients admitted for MFS, 51 were tested for ganglioside antibodies. Only 9 (17.65%) of the tested patients were found to have the anti-GQ1b IgG antibody. The positivity rate of the antibody was comparable between patients with the complete form of MFS and those with the incomplete form (17.39% vs. 17.86%, P = 0.965). Additionally, the positivity rate was significantly lower during and after the COVID-19 pandemic compared to before the pandemic (8.33% vs. 40.00%, P = 0.007).</p><p><strong>Conclusions: </strong>The anti-GQ1b IgG antibody is infrequently detected in MFS patients admitted to our center, especially during and after the COVID-19 pandemic. Future prospective multicenter investigations are expected to contribute significantly to the further clarification of the prevalence of anti-GQ1b IgG antibody in MFS patients across various regions of China.</p>","PeriodicalId":19191,"journal":{"name":"Neurological Sciences","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144248905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence empowers physical therapy for neurological conditions. 人工智能使神经系统疾病的物理治疗成为可能。
IF 2.7 4区 医学
Neurological Sciences Pub Date : 2025-06-09 DOI: 10.1007/s10072-025-08295-4
Jie Hao
{"title":"Artificial intelligence empowers physical therapy for neurological conditions.","authors":"Jie Hao","doi":"10.1007/s10072-025-08295-4","DOIUrl":"https://doi.org/10.1007/s10072-025-08295-4","url":null,"abstract":"","PeriodicalId":19191,"journal":{"name":"Neurological Sciences","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144258543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum sirtuin 3 levels and multimodal abnormalities in brain structure and function in Parkinson's disease patients with depression. 帕金森病伴抑郁患者血清sirtuin 3水平与脑结构和功能多模态异常
IF 2.7 4区 医学
Neurological Sciences Pub Date : 2025-06-09 DOI: 10.1007/s10072-025-08289-2
Mahnoor Sultana, Ayesha Parvaiz Malik, Javed Iqbal, Brijesh Sathian
{"title":"Serum sirtuin 3 levels and multimodal abnormalities in brain structure and function in Parkinson's disease patients with depression.","authors":"Mahnoor Sultana, Ayesha Parvaiz Malik, Javed Iqbal, Brijesh Sathian","doi":"10.1007/s10072-025-08289-2","DOIUrl":"https://doi.org/10.1007/s10072-025-08289-2","url":null,"abstract":"","PeriodicalId":19191,"journal":{"name":"Neurological Sciences","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144248906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信